4.6 Review

The MHC-II transactivator CIITA, a restriction factor against oncogenic HTLV-1 and HTLV-2 retroviruses: similarities and differences in the inhibition ofTax-1 andTax-2 viral transactivators

期刊

FRONTIERS IN MICROBIOLOGY
卷 4, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fmicb.2013.00234

关键词

restriction factors; CIITA; HTLV-1 Tax-1; HTLV-2 Tax-2; viral replication

资金

  1. Fondazione Cariplo Cellular and molecular basis of human retroviral-dependent pathology [2008-2230]
  2. Associazione Hallam Ricerca sul Cancro New strategies of tumor vaccination and immunotherapy based on optimized triggering of anti tumor CD4 T cells [AIRC IG 8862]
  3. Italian Ministry of University and Research project PRIN
  4. Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom

向作者/读者索取更多资源

The activation of CD4(+) T helper cells is strictly dependent on the presentation of antigenic peptides by MHC class 11 (MHC-II) molecules. MHC-II expression is primarily regulated at the transcriptional level by the AIR-1 gene product CIITA (class 11 transactivator). Thus, CIITA plays a pivotal role in the triggering of the adaptive immune response against pathogens. Besides this well known function, we recently found that CIITA acts as an endogenous restriction factor against HTLV-1 (human T cell lymphotropic virus type 1) and HTLV-2 oncogenic retroviruses by targeting their viral transactivators Tax-1 and Tax-2, respectively. Here we review our findings on CIITA-mediated inhibition of viral replication and discuss similarities and differences in the molecular mechanisms by which CIITA specifically counteracts the function of Tax-1 and Tax-2 molecules. The dual function of CIITA as a key regulator of adaptive and intrinsic immunity represents a rather unique example of adaptation of host-derived factors against pathogen infections during evolution.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据